The Impact of Prescription Therapies for Warts and Molluscum
Recommended Citation
Heron C, Jahnke M. The Impact of Prescription Therapies for Warts and Molluscum. Pediatr Clin North Am. 2026;73(4):741-754.
Document Type
Article
Publication Date
8-1-2026
Publication Title
Pediatric clinics of North America
Keywords
Humans, Warts, Molluscum Contagiosum
Abstract
Molluscum contagiosum (MC) and verruca vulgaris are common infectious skin conditions encountered by pediatric clinicians. There is substantial overlap between treatment options for both conditions, and the most effective regimens often use a combination of in-office and at-home treatments. There are innumerable treatments for both conditions. This article focuses on familiarizing the pediatric provider with prescription topical therapies for both conditions including cantharidin, imiquimod, and retinoids, as well as berdazimer sodium for MC and 5-fluorouracil and diphenylcyclopropenone and Squaric Acid Dibutyl Ester for viral warts. Other therapies including injections and oral medications will also be discussed.
Medical Subject Headings
Humans; Warts; Molluscum Contagiosum
PubMed ID
42349977
Volume
73
Issue
4
First Page
741
Last Page
754
